Sphaera Pharma Research and Development

Sphaera Pharma is a drug discovery and development company with a focus on creating novel small molecule therapeutics for oncology, metabolic disorders, and inflammatory conditions. Headquartered in Singapore with a major R&D center in India, the company utilizes its proprietary technology platforms to optimize the pharmacological profiles of its drug candidates. Sphaera's business model combines internal pipeline development with strategic out-licensing, as evidenced by its partnership with JW Pharmaceutical for its lead renin inhibitor. The leadership team comprises industry veterans with extensive experience in global pharmaceutical research and development. The company's pipeline includes several candidates in various stages of development, ranging from pre-clinical to Phase 2 clinical trials. Sphaera aims to address significant unmet medical needs through innovative chemistry and efficient drug design.